According to Dr. Natalia Kruglova, a Russian nutrition expert, a teaspoon of natural bee honey contains about 5-6 grams of sugar.
The doctor indicates that, based on the safe daily amount of sugar of 30 grams, it is possible to eat no more than six teaspoons of honey daily, provided that you do not eat any other type of sweets. However, there is no specific period of the day to eat honey.
“There is a myth that honey causes weight gain, so it should only be consumed in the first half of the day,” she says. “This is wrong. Because the total calorie content of the diet has a greater impact.”
The doctor advises giving preference to honey that has not undergone heat treatment, because it retains the greatest amount of beneficial nutrients. But it is not recommended to give it to children under one year old.
“On the one hand, this is because honey causes allergies,” she says. “On the other hand, it may contain botulism triggers, which are unlikely to be present in large numbers, but for a child they are many. But at the same time, their presence will not lead to No clinical manifestations in adults.
Cholesterol medications may stop a fatal condition in men!
Cholesterol-lowering medications could revolutionize the treatment of abdominal aortic aneurysms (AAAs), saving hundreds of lives every year.
AAA is a balloon-like swelling in the lower part of the aorta, which is the main artery in the body that pumps blood from the heart to the rest of the body.
If it is not treated, it can grow and burst, causing life-threatening bleeding.
Aneurysms are thought to be caused by changes in the artery wall due to aging, smoking and high blood pressure, but the condition also runs in families.
The condition is also known to be six times more common among men than women, and affects about 4% of men over the age of 65 years.
Symptoms of AAA include persistent stomach pain, back pain, and a pulsating sensation near the belly button. However, most cases do not show symptoms.
Now, a new study reveals that medications already used to lower cholesterol can slow aneurysm growth and reduce - or even prevent - the need for surgery.
In the study, published in the journal Nature Genetics, researchers compared the DNA of about 40,000 people with AAA with 1 million people without the condition.
This revealed about 150 pieces of DNA involved in aneurysm development. This includes a gene that makes a protein called PCSK9, which is made in the liver, and prevents the breakdown of harmful LDL cholesterol.
As part of the research, studies in mice also showed that AAAs grew more slowly in those that were unable to produce PCSK9, suggesting that drugs that lower PCSK9 levels could be beneficial.
Such drugs, known as PCSK9 inhibitors, are used to lower cholesterol when existing treatments such as statins are not effective enough.
Two PCSK9 inhibitors, alirocumab and evolocumab, have already been licensed for use in the UK, although they have yet to be tried in AAA patients.
Clinical studies could begin within two years, and the drugs could be widely used to treat abdominal aortic aneurysms by 2030, according to Matthew Bown, professor of vascular surgery at the University of Leicester and one of the study's principal investigators.
It is not known how cholesterol fuels aneurysm growth. However, one possibility is that high cholesterol leads to inflammation that weakens the walls of the aorta.